Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
brentuximab vedotin (adcetris) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
dacarbazine (dtic-dome) (1 trial)
doxorubicin (Doxil) (1 trial)
etoposide (vepesid) (1 trial)
vinblastine (velban) (1 trial)
Hodgkin Disease (Phase 2)
Lymphoma (Phase 2)
Trials (1 total)
Trial APIs (6 total)